ArticleBiotechnology letters2025
Effects of cultivation conditions on D-aspartate production by the lactic acid bacterium Latilactobacillus curvatus strain WDN19.
Article in Biotechnology letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Recent progress in microbial production of D-aspartate.World journal of microbiology & biotechnology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
D-Asp is a pharmaceutically valuable amino acid used as an antibiotic precursor and has potential therapeutic benefits for neurological disorders and reproductive health. The lactic acid bacterium Latilactobacillus curvatus strain WDN19, originally isolated from a salt-fermented pickle, produces large amounts of D-Asp from L-Asp. To optimize D-Asp production, we investigated the effects of various cultivation conditions. Growth and D-Asp formation increased concomitantly with temperature, reaching a maximum at 37 °C, whereas no growth occurred at 40 °C. L-Asp concentrations ≤ 100 mM minimally affected biomass, yet higher levels curtailed both growth and conversion, revealing an intrinsic racemization capacity of ~ 30 mM under unbuffered conditions. Strain WDN19 grew across an initial pH range of 5.0-9.5, but rapid acidification to pH ≈ 4.5 triggered severe cell death and arrested D-Asp synthesis. Incorporation of 500 mM 2-morpholinoethanesulfonic acid maintained near-neutral pH, preserved viability, and enabled almost quantitative racemization of up to 500 mM L-Asp within 48 h, yielding > 250 mM D-Asp. These findings establish pH control as the critical determinant for high-yield D-Asp production by strain WDN19, providing a practical framework for environmentally friendly, fermentation-based manufacturing of this pharmaceutically valuable amino acid.
Indexed as
Identifiers
41398542What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.